Genistein suppresses proliferation and MET oncogene expression and induces EGR-1 tumor suppressor expression in immortalized human breast epithelial cells

Anticancer Research

Volumn 26, Issue 2 A, 2006, Pages 1039-1048

  Singletary, Keith ^a   Ellington, Allison ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Breast epithelial cells; Egr 1; Fos; Genistein; Jun; Met

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; GENISTEIN; PROTEIN FOS; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR SP1;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER INHIBITION; CANCER RISK; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; FOOD INTAKE; HUMAN; HUMAN CELL; MENOPAUSE; ONCOGENE; PREMENOPAUSE; PRIORITY JOURNAL; PROTO ONCOGENE; SOYBEAN;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; EARLY GROWTH RESPONSE PROTEIN 1; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, FOS; GENES, JUN; GENISTEIN; HUMANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, GROWTH FACTOR; RNA, MESSENGER; UP-REGULATION;

EID: 33645824142     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari R, Ghafoor A, Feuer E and Thun M: Cancer statistics, 2005. CA Cancer J Clin 55: 10-30, 2005.
2. Dumitrescu R and Cotarla I: Understanding breast cancer risk - where do we stand in 2005? J Cell Mol Med 9: 208-221, 2005.
3. Adlercreutz H: Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol 83: 113-118, 2003.
4. Peeters P, Keinan-Boker L, van der Schouw Y and Grobbee D: Phytoestrogens and breast cancer risk. Review of the epidemiological evidence. Breast Cancer Res Treat 77: 171-183, 2003.
5. Shu X, Jin F, Dai Q, Wen W, Potter J, Kushi L, Ruan Z, Gao Y and Zheng W: Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 10: 483-488, 2001.
6. Wu A, Wan P, Hankin J, Tseng C, Yu M and Pike M: Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23: 1491-1496, 2002.
7. Adlercreutz H: Phyto-estrogens and cancer. Lancet Oncol 3: 364-373, 2002.
8. Brown N and Lamartiniere C: Xenoestrogens alter mammary gland differentiation and cell proliferation in the rat. Environ Health Perspect 103: 708-713, 1995.
9. Murrill W, Brown N, Zhang J, Manzolillo P, Barnes S and Lamartiniere C: Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17: 1451-1457, 1996.
10. Lamartiniere C, Zhang J and Cotroneo M: Genistein studies in rats: potential for breast cancer prevention and reproductive and developmental toxicity. Am J Clin Nutr 68: 1400S-1405S, 1988.
11. Lamartiniere C: Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr 71: 1705S-1707S, 2000.
12. Hilakivi-Clarke L, Onojafe I, Raygada M, Cho E, Skaar T, Russo I and Clarke R: Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br J Cancer 80: 1682-1688, 1999.
13. Cabanes A, Wang M, Olivo S, DeAssis S, Gustafsson J, Khan G and Hilakivi-Clarke L: Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis 25: 741-748, 2004.
14. Frey R, Li J and Singletary K: Effects of genistein on cell proliferation and cell cycle arrest in nonneoplastic human mammary epithelial cells: involvement of Cdc2, p21(waf/cip1), p27(kip1), and Cdc25C expression. Biochem Pharmacol 61: 979-989, 2001.
15. Frey R and Singletary K: Genistein activates p38 mitogen-activated protein kinase, inactivates ERK1/ERK2 and decreases Cdc25C expression in immortalized human mammary epithelial cells. J Nutr 133: 226-231, 2003.
16. Upadhyay S, Neburi M, Chinni S, Alhasan S, Miller F and Sarkar F: Differential sensitivity of normal and malignant breast epithelial cells to genistein is partly mediated by p21(WAF1). Clin Cancer Res 7: 1782-1789, 2001.
17. Adlercreutz H, Markkanen H and Watanabe S: Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342: 1209-1210, 1993.
18. Xu X, Harris K, Wang H, Murphy P and Hendrich S: Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr 125: 2307-2315, 1995.
19. Coward L, Kirk M, Albin N and Barnes S: Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry. Clin Chim Acta 247: 121-142, 1996.
20. McMichael-Phillips D, Harding C, Morton M, Roberts S, Howell A, Potten C and Bundred N: Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am J Clin Nutr 68: 1431S-1435S, 1998.
21. Christensen J, Burrows J and Salgia R: c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention. Cancer Lett 225: 1-26, 2005.
22. Gallego M, Bierie B and Hennighausen L: Targeted expression of HGF/SF in mouse mammary epithelium leads to metastatic adenosquamous carcinomas through the activation of multiple signal transduction pathways. Oncogene 22: 8498-8508, 2003.
23. Welm A, Kim S, Welm B and Bishop J: MET and MYC cooperate in mammary tumorigenesis. PNAS USA 102: 4324-4329, 2005.
24. Parr, C, Watkins G, Mansel R and Jiang W: The hepatocyte growth factor regulatory factors in human breast cancer. Clin Cancer Res 10: 202-211, 2004.
25. Jiang W, Grimshaw D, Martin T, Davies G, Parr C, Watkins G, Lane J, Abounader R, Laterra J and Mansel R: Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-met. Clin Cancer Res 9: 4274-4281, 2003.
26. Huang R, Fan Y, de Belle I, Niemeyer C, Gottardis M, Mercola D and Adamson E: Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer 72: 102-109, 1997.
27. Krones-Herzig A, Adamson E and Mercola D: Early growth response 1 protein, an upstream gatekeeper of the p53 tumor suppressor, controls replicative senescence. PNAS USA 100: 3233-3238, 2003.
28. Krones-Herzog A, Mittal S, Yule K, Liang H, English C, Urcis R, Soni T, Adamson E and Mercola D: Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53. Cancer Res 65: 5133-5143, 2005.
29. Baron V, Adamson E, Calogro A, Ragona G and Mercola D: The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFb1, PTEN, p53, and fibronectin. Cancer Gene Ther (in press).
30. Mitchel A, Dass C, Sun L and Khachigian L: Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1. Nucl Acids Res 32: 3065-3069, 2004.
31. Adamson E and Mercola D: Egr-1 transcription factor: multiple roles in prostate tumor cell growth and survival. Tumor Biol 23: 93-102, 2002.
32. Yu J, Belle I, Liang H and Adamson E: Coactivating factors p300 and CBP transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses. Mol Cell 75: 83-94, 2004.
33. Liang H, O'Reilly S, Liu Y, Aboundader R, Laterra J, Maher V and McCormick J: Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity. Int J Oncol 24: 1057-1067, 2004.
34. Zhang X and Liu Y: Suppression of HGF receptor gene expression by oxidative stress is mediated through the interplay between Sp1 and Egr-1. Am J Physiol Renal Physiol 284: F1216-F1225, 2003.
35. Birchmeier C, Birchmeier W, Gherardi E and Vande Woude G: Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4: 915-925, 2003.
36. Thiel G and Cibelli G: Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 193: 287-292, 2002.
37. Ronski K, Sanders M, Burleson J, Moyo V, Benn P and Fang M: Early growth response gene 1 (EGR1) is deleted in estrogen receptor-negative human breast carcinoma. Cancer 104: 925-930, 2005.
38. Zarnegar R: Regulation of HGF and HGFR gene expression. In: Epithelial-Mesenchymal Interactions in Cancer (Goldberg and Rosen, eds.). Birkhaüser Verlag, Basel, pp. 33-49, 1995.
39. Gambarotta G, Pistoi S, Giordano S, Comoglio P and Santoto C: Structure and inducible regulation of the human MET promoter. J Biol Chem 269: 12852-12857, 1994.
40. Liu Y: The human hepatocyte growth factor receptor gene: complete structural organization and promoter characterization. Gene 215: 159-169, 1998.
41. Seol D and Zarnegar R: Structural and functional characterization of the mouse c-met proto-oncogene (hepatocyte growth factor receptor) promoter. Biochim Biophys Acta 1395: 252-258, 1988.
42. Eferl R and Wagner E: AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3859-3868, 2003.
43. Maggiolini M, Vivacqua A, Fasanella G, Recchia A, Sisci D, Pezzi V, Montanaro D, Musti A, Picard D and Ando S: The G-protein-coupled receptor GPR30 mediates c-fos up-regulation by 17β-estradiol and phytoestrogens in breast cancer cells. J Biol Chem 279: 27008-27016, 2004.
44. Shen Q and Brown P: Novel agents for the prevention of breast cancer: targeting transcription factors and signal transduction pathways. J Mamm Gland Biol Neopl 8: 45-73, 2003.
45. Vogt P: Jun, the oncoprotein. Oncogene 20: 2365-2377, 2001.
46. Lu C, Shen Q, DuPre E, Kim H, Hilsinbeck S and Brown P: cFos is critical for MCF-7 breast cancer cell growth. Oncogene, in press.
47. Wang Q, Salman H, Danilenko M and Studzinski G: Cooperation between antioxidants and 1,25-dihydroxyvitamin D3 in induction of leukemia HL60 cell differentiation through the JNK/AP-1/Egr-1 pathway. J Cell Physiol 204: 964-974, 2005.
48. Huang Y, Boskovic G and Niles R: Retinoic acid-induced AP-1 transcriptional activity regulates B16 mouse melanoma growth inhibition and differentiation. J Cell Physiol 194: 162-170, 2003.
49. Altucci L and Gronemeyer H: The promise of retinoids to fight against cancer. Nature Rev Cancer 1: 181-193, 2001.
50. Müller J, Cahill M, Rupec R, Baeuerle P and Nordheim A: Antioxidants as well as oxidants activate c-fos via Ras-dependent activation of extracellular-signal-regulated kinase 2 and Elk-1. Eur J Biochem 244: 45-52, 1997.
51. Darland T, Samuels M, Edwards S, Sukhatme V and Adamson E: Regulation of Egr-1 (Zfp-6) and c-fos expression in differentiating embryonal carcinoma cells. Oncogene 6: 1367-1376, 1991.
52. Erickson-Miller C, Pelus L and Lord K: Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation. Stem Cells 18: 366-373, 2000.
53. Sukhatme V, Cao X, Chang L, Tsai-Morris C, Stamenkovich D, Ferreira P, Cohen D, Edwards S, Shows T and Curran T: A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53: 37-43, 1998.
54. Gineitis D and Treisman R: Differential usage of signal transduction pathways defines two types of serum response factor target gene. J Biol Chem 276: 24531-24539, 2001.
55. Levkovitz Y and Baraban J: A dominant negative Egr inhibitor blocks nerve growth factor-inducible neurite outgrowth by suppressing c-Jun activation: role of an Egr/c-Jun complex. J Neuroscience 22: 3845-3854, 2002.
56. Murphy L, MacKeigan J and Blenis J: A network of immediate-early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration. Mol Cell Biol 24: 144-153, 2004.